RISKY BEHAVIORS WITH NONALCOHOLIC FATTY LIVER (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) AMONG OLDER ADULTS

被引：0

作者：

Tseng, Tung-Sung ^{[1
]}

Lin, Wei-Ting ^{[2
]}

Ting, Peng-sheng ^{[3
]}

Huang, Chiung-Kuei ^{[3
]}

Chen, Po-Hung ^{[4
]}

Lin, Hui-Yi ^{[1
]}

机构：

[1] LSUHSC, New Orleans, LA USA

[2] Tulane Univ, New Orleans, LA USA

[3] Tulane Univ, Sch Med, New Orleans, LA USA

[4] Johns Hopkins Univ, Med, Baltimore, MD USA

来源：

INNOVATION IN AGING | 2023年 / 7卷

关键词：

D O I：

暂无

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

igad104.25

引用

页码：780 / 780

页数：1

共 50 条

[21] Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): prevalence, therapeutic innovations, and stumbling blocks for clinical development
Alkhouri, Naim
[J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (02) : 115 - 116
[22] EMPHASIZING DIVERSITY IN NONALCOHOLIC STEATOHEPATITIS (NASH) STUDIES: CHARACTERIZATION OF A NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) SCREENING DATABASE.
Paglialunga, S.
Jaycox, S.
Kar, S.
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S39 - S39
[23] Effect of Metformin on Ballooning Degeneration in Nonalcoholic Steatohepatitis (NASH): When to Use Metformin in Nonalcoholic Fatty Liver Disease (NAFLD)
Doycheva, Iliana
Loomba, Rohit
[J]. ADVANCES IN THERAPY, 2014, 31 (01) : 30 - 43
[24] Effect of Metformin on Ballooning Degeneration in Nonalcoholic Steatohepatitis (NASH): When to Use Metformin in Nonalcoholic Fatty Liver Disease (NAFLD)
Iliana Doycheva
Rohit Loomba
[J]. Advances in Therapy, 2014, 31 : 30 - 43
[25] Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain
Romero-Gomez, Manuel
Kachru, Nandita
Zamorano, Meritxell Ascanio
Darba, Josep
Shreay, Sanatan
[J]. MEDICINE, 2020, 99 (50): : E23506
[26] PATHOGENETIC ANALYSIS OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) WITH MULTI-CELL-LINEAGE HUMAN LIVER ORGANOIDS
Zhang, Wenjun
Park, Yujin
Thadasina, Deepthi
Thi Minh Uyen Le
Li, Ping
Ekser, Burcin
[J]. HEPATOLOGY, 2023, 78 : S1121 - S1122
[27] Prevalence and predictors of de novo nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) after orthotopic liver transplantation (OLT)
Seo, Suk
Maganti, Kalyani
Khehra, Manjit
Ramsamooj, Rajendra
Tsodikov, Alexander
Torok, Natalie
[J]. GASTROENTEROLOGY, 2006, 130 (04) : A789 - A789
[28] Liver Transplantation for Nonalcoholic Steatohepatitis (NASH) in Children and Young Adults: The True Burden of Pediatric Nonalcoholic Fatty Liver Disease
Alkhouri, Naim
Hanouneh, Ibrahim A.
Zein, Nizar N.
Lopez, Rocio
Kelly, Dympna
Eghtesad, Bijan
Fung, John J.
[J]. GASTROENTEROLOGY, 2015, 148 (04) : S1046 - S1046
[29] Effect of Roux-en-Y Reconstruction on Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH)
Kashihara, Hideya
Yoshikawa, Kozo
Higashijima, Jun
Nishi, Masaaki
Takasu, Chie
Shimada, Mitsuo
[J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 225 (04) : E58 - E59
[30] Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH)
Wen, Xuerong
Wang, Shuang
Taveira, Tracey H.
Akhlaghi, Fatemeh
[J]. PLOS ONE, 2021, 16 (09):

← 1 2 3 4 5 →